PALISADE BIO, INC. Operating Expenses
PALISADE BIO, INC. (PALI) reported Operating Expenses of $12.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-10
- PALISADE BIO, INC. operating expenses for the quarter ending 2026-06-30 was $12.20M, a 329.05% increase year-over-year.
- PALISADE BIO, INC. operating expenses for the quarter ending 2026-03-31 was $10.75M, a 365.28% increase year-over-year.
- PALISADE BIO, INC. operating expenses for the quarter ending 2025-12-31 was $9.98M, a 195.12% increase year-over-year.
- PALISADE BIO, INC. operating expenses for the quarter ending 2025-09-30 was $2.92M, a 18.68% decline year-over-year.
- PALISADE BIO, INC. operating expenses for fiscal 2025 was $18.06M, a 21.52% increase from fiscal 2024.
- PALISADE BIO, INC. operating expenses for fiscal 2024 was $14.86M, a 11.55% increase from fiscal 2023.
- PALISADE BIO, INC. operating expenses for fiscal 2023 was $13.32M, a 15.27% decline from fiscal 2022.
- PALISADE BIO, INC. operating expenses for fiscal 2022 was $15.72M, a 62.44% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.20M 10-Q · filed 2026-08-10 | $22.95M 10-Q · filed 2026-08-10 | $32.93M derived: sum of 3 quarters · filed 2026-08-10 | $35.85M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $10.75M 10-Q · filed 2026-05-12 | $20.73M derived: sum of 2 quarters · filed 2026-05-12 | $23.65M derived: sum of 3 quarters · filed 2026-05-12 | $26.49M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $9.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $12.90M derived: sum of 2 quarters · filed 2026-03-20 | $15.75M derived: sum of 3 quarters · filed 2026-08-10 | $18.06M 10-K · filed 2026-03-20 | ||||
| 2025-09-30 | $2.92M 10-Q · filed 2025-11-10 | $5.76M derived: sum of 2 quarters · filed 2026-08-10 | $8.07M 10-Q · filed 2025-11-10 | $11.46M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $2.84M 10-Q · filed 2026-08-10 | $5.15M 10-Q · filed 2026-08-10 | $8.54M derived: sum of 3 quarters · filed 2026-08-10 | $12.13M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $2.31M 10-Q · filed 2026-05-12 | $5.69M derived: sum of 2 quarters · filed 2026-05-12 | $9.29M derived: sum of 3 quarters · filed 2026-05-12 | $13.50M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $6.97M derived: sum of 2 quarters · filed 2026-03-20 | $11.19M derived: sum of 3 quarters · filed 2026-03-20 | $14.86M 10-K · filed 2026-03-20 | ||||
| 2024-09-30 | $3.59M 10-Q · filed 2025-11-10 | $7.80M derived: sum of 2 quarters · filed 2025-11-10 | $11.48M 10-Q · filed 2025-11-10 | $14.63M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $4.21M 10-Q · filed 2025-08-11 | $7.88M 10-Q · filed 2025-08-11 | $11.04M derived: sum of 3 quarters · filed 2025-08-11 | $14.82M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $3.67M 10-Q · filed 2025-05-12 | $6.83M derived: sum of 2 quarters · filed 2025-05-12 | $10.61M derived: sum of 3 quarters · filed 2025-05-12 | $14.21M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $6.93M derived: sum of 2 quarters · filed 2025-03-24 | $10.54M derived: sum of 3 quarters · filed 2025-03-24 | $13.32M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $3.78M 10-Q · filed 2024-11-12 | $7.39M derived: sum of 2 quarters · filed 2024-11-12 | $10.17M 10-Q · filed 2024-11-12 | $14.01M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $3.61M 10-Q · filed 2024-08-12 | $6.39M 10-Q · filed 2024-08-12 | $10.24M derived: sum of 3 quarters · filed 2024-08-12 | $14.65M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $2.78M 10-Q · filed 2024-05-13 | $6.63M derived: sum of 2 quarters · filed 2024-05-13 | $11.04M derived: sum of 3 quarters · filed 2024-05-13 | $14.61M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $8.26M derived: sum of 2 quarters · filed 2024-03-26 | $11.83M derived: sum of 3 quarters · filed 2024-03-26 | $15.72M 10-K · filed 2024-03-26 | ||||
| 2022-09-30 | $4.41M 10-Q · filed 2023-11-09 | $7.99M derived: sum of 2 quarters · filed 2023-11-09 | $11.87M 10-Q · filed 2023-11-09 | $15.90M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $3.57M 10-Q · filed 2023-08-10 | $7.46M 10-Q · filed 2023-08-10 | $11.49M derived: sum of 3 quarters · filed 2023-08-10 | $14.50M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $3.89M 10-Q · filed 2023-05-11 | $7.92M derived: sum of 2 quarters · filed 2023-05-11 | $10.93M derived: sum of 3 quarters · filed 2023-05-11 | $43.79M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $7.04M derived: sum of 2 quarters · filed 2023-03-22 | $39.90M derived: sum of 3 quarters · filed 2023-03-22 | $41.85M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $3.02M 10-Q · filed 2022-11-14 | $35.87M derived: sum of 2 quarters · filed 2022-11-14 | $37.83M 10-Q · filed 2022-11-14 | $41.07M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $32.86M 10-Q · filed 2022-08-15 | $34.81M 10-Q · filed 2022-08-15 | $38.06M derived: sum of 3 quarters · filed 2022-08-15 | $39.87M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $1.95M 10-Q · filed 2022-05-13 | $2.19M 10-Q · filed 2021-05-14 | $5.20M derived: sum of 2 quarters · filed 2022-05-13 | $7.01M derived: sum of 3 quarters · filed 2022-05-13 | $8.86M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $5.06M derived: sum of 2 quarters · filed 2022-03-17 | $6.90M derived: sum of 3 quarters · filed 2022-03-17 | $9.30M 10-K · filed 2022-03-17 | $10.69M 10-K · filed 2021-03-22 | |||
| 2020-09-30 | $1.82M 10-Q · filed 2021-11-12 | $2.35M 10-Q · filed 2020-11-10 | $3.66M derived: sum of 2 quarters · filed 2021-11-12 | $6.05M 10-Q · filed 2021-11-12 | $6.29M 10-Q · filed 2020-11-10 | $7.79M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $1.84M 10-Q · filed 2021-08-23 | $1.95M 10-Q · filed 2020-08-13 | $4.24M 10-Q · filed 2021-08-23 | $3.95M 10-Q · filed 2020-08-13 | $5.97M derived: sum of 3 quarters · filed 2021-08-23 | $8.10M derived: sum of 4 quarters · filed 2021-08-23 | ||
| 2020-03-31 | $2.00M 10-Q · filed 2021-05-14 | $4.13M derived: sum of 2 quarters · filed 2021-05-14 | $6.26M derived: sum of 3 quarters · filed 2021-05-14 | $8.18M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $4.26M derived: sum of 2 quarters · filed 2021-03-22 | $6.19M derived: sum of 3 quarters · filed 2021-03-22 | $8.65M 10-K · filed 2021-03-22 | ||||
| 2019-09-30 | $2.13M 10-Q · filed 2020-11-10 | $4.05M derived: sum of 2 quarters · filed 2020-11-10 | $6.51M 10-Q · filed 2020-11-10 | $8.32M derived: sum of 4 quarters · filed 2020-11-10 | ||||
| 2019-06-30 | $1.93M 10-Q · filed 2020-08-13 | $4.39M 10-Q · filed 2020-08-13 | $6.19M derived: sum of 3 quarters · filed 2020-08-13 | $8.28M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $2.46M 10-Q · filed 2020-05-15 | $4.27M derived: sum of 2 quarters · filed 2020-05-15 | $6.35M derived: sum of 3 quarters · filed 2020-05-15 | $8.63M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $3.89M derived: sum of 2 quarters · filed 2020-03-27 | $6.17M derived: sum of 3 quarters · filed 2020-03-27 | $8.52M 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | $2.09M 10-Q · filed 2019-11-14 | $4.36M derived: sum of 2 quarters · filed 2019-11-14 | $6.71M 10-Q · filed 2019-11-14 | $9.23M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $2.28M 10-Q · filed 2019-08-14 | $4.63M 10-Q · filed 2019-08-14 | $7.15M derived: sum of 3 quarters · filed 2019-08-14 | $9.74M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $2.35M 10-Q · filed 2019-05-14 | $4.87M derived: sum of 2 quarters · filed 2019-05-14 | $7.46M derived: sum of 3 quarters · filed 2019-05-14 | $11.68M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $5.11M derived: sum of 2 quarters · filed 2019-03-22 | $9.33M derived: sum of 3 quarters · filed 2019-03-22 | $13.57M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $2.59M 10-Q · filed 2018-11-14 | $6.81M derived: sum of 2 quarters · filed 2018-11-14 | $11.05M 10-Q · filed 2018-11-14 | $16.71M derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | $4.22M 10-Q · filed 2018-08-13 | $8.46M 10-Q · filed 2018-08-13 | $14.12M derived: sum of 3 quarters · filed 2018-08-13 | $19.04M derived: sum of 4 quarters · filed 2018-08-13 | ||||
| 2017-03-31 | $4.23M 10-Q · filed 2018-05-15 | $9.90M derived: sum of 2 quarters · filed 2018-05-15 | $14.81M derived: sum of 3 quarters · filed 2018-05-15 | $18.65M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $10.58M derived: sum of 2 quarters · filed 2018-04-02 | $14.42M derived: sum of 3 quarters · filed 2018-04-02 | $20.65M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $4.92M 10-Q · filed 2017-11-08 | $8.76M derived: sum of 2 quarters · filed 2017-11-08 | $14.99M 10-Q · filed 2017-11-08 | $19.35M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $3.84M 10-Q · filed 2017-08-08 | $10.07M 10-Q · filed 2017-08-08 | $14.43M derived: sum of 3 quarters · filed 2017-08-08 | $19.63M derived: sum of 4 quarters · filed 2017-08-08 | ||||
| 2016-03-31 | $6.24M 10-Q · filed 2017-05-10 | $10.59M derived: sum of 2 quarters · filed 2017-05-10 | $15.79M derived: sum of 3 quarters · filed 2017-05-10 | $20.79M derived: sum of 4 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-23 | $9.55M derived: sum of 2 quarters · filed 2017-03-23 | $14.55M derived: sum of 3 quarters · filed 2017-03-23 | $19.17M 10-K · filed 2017-03-23 | ||||
| 2015-09-30 | $5.20M 10-Q · filed 2016-11-08 | $10.20M derived: sum of 2 quarters · filed 2016-08-11 | $14.81M 10-Q · filed 2016-11-08 | $19.46M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-06-30 | $5.00M 10-Q · filed 2016-08-11 | $9.61M 10-Q · filed 2016-08-11 | $14.26M derived: sum of 3 quarters · filed 2016-08-11 | $18.37M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | $4.62M 10-Q · filed 2016-05-09 | $9.26M derived: sum of 2 quarters · filed 2016-05-09 | $13.37M derived: sum of 3 quarters · filed 2016-05-09 | $16.89M derived: sum of 4 quarters · filed 2016-05-09 | ||||
| 2014-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $8.76M derived: sum of 2 quarters · filed 2016-03-14 | $12.27M derived: sum of 3 quarters · filed 2016-03-14 | $17.45M 10-K · filed 2016-03-14 | ||||
| 2014-09-30 | $4.11M 10-Q · filed 2015-11-09 | $7.63M derived: sum of 2 quarters · filed 2015-11-09 | $12.81M 10-Q · filed 2015-11-09 | $15.57M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | $3.52M 10-Q · filed 2015-08-10 | $8.70M 10-Q · filed 2015-08-10 | $11.46M derived: sum of 3 quarters · filed 2016-03-14 | $15.10M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | $5.18M 10-Q · filed 2015-05-08 | $7.95M derived: sum of 2 quarters · filed 2016-03-14 | $11.58M derived: sum of 3 quarters · filed 2016-03-14 | $14.82M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2013-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $6.40M derived: sum of 2 quarters · filed 2016-03-14 | $9.64M derived: sum of 3 quarters · filed 2016-03-14 | $12.63M 10-K · filed 2016-03-14 | ||||
| 2013-09-30 | $3.64M 10-Q · filed 2014-11-07 | $6.87M derived: sum of 2 quarters · filed 2014-11-07 | $9.87M 10-Q · filed 2014-11-07 | $12.60M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-06-30 | $3.24M 10-Q · filed 2014-08-08 | $6.23M 10-Q · filed 2014-08-08 | $8.96M derived: sum of 3 quarters · filed 2015-03-16 | $11.72M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2013-03-31 | $2.99M 10-Q · filed 2014-05-12 | $5.72M derived: sum of 2 quarters · filed 2015-03-16 | $8.48M derived: sum of 3 quarters · filed 2015-03-16 | $10.94M derived: sum of 4 quarters · filed 2015-03-16 | ||||
| 2012-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $5.48M derived: sum of 2 quarters · filed 2015-03-16 | $7.94M derived: sum of 3 quarters · filed 2015-03-16 | $10.56M 10-K · filed 2015-03-16 | ||||
| 2012-09-30 | $2.75M 10-Q · filed 2013-11-12 | $5.22M derived: sum of 2 quarters · filed 2013-11-12 | $7.83M 10-Q · filed 2013-11-12 | $10.68M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-06-30 | $2.46M 10-Q · filed 2013-08-08 | $5.08M 10-Q · filed 2013-08-08 | $7.93M derived: sum of 3 quarters · filed 2014-03-10 | $11.26M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-03-31 | $2.62M 10-Q · filed 2013-05-10 | $5.47M derived: sum of 2 quarters · filed 2014-03-10 | $8.80M derived: sum of 3 quarters · filed 2014-03-10 | $12.46M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2011-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $6.18M derived: sum of 2 quarters · filed 2014-03-10 | $9.84M derived: sum of 3 quarters · filed 2014-03-10 | $13.38M 10-K · filed 2014-03-10 | ||||
| 2011-09-30 | $3.33M 10-Q · filed 2012-11-09 | $7.00M derived: sum of 2 quarters · filed 2012-11-09 | $10.53M 10-Q · filed 2012-11-09 | $14.71M derived: sum of 4 quarters · filed 2012-11-09 | ||||
| 2011-06-30 | $3.67M 10-Q · filed 2012-08-09 | $7.21M 10-Q · filed 2012-08-09 | $11.39M derived: sum of 3 quarters · filed 2012-08-09 | $15.31M derived: sum of 4 quarters · filed 2012-08-09 | ||||
| 2011-03-31 | $3.54M 10-Q · filed 2012-05-09 | $7.72M derived: sum of 2 quarters · filed 2012-05-09 | $11.64M derived: sum of 3 quarters · filed 2012-05-09 | $15.84M derived: sum of 4 quarters · filed 2012-05-09 | ||||
| 2010-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $8.11M derived: sum of 2 quarters · filed 2012-03-30 | $12.30M derived: sum of 3 quarters · filed 2012-03-30 | $15.92M 10-K · filed 2012-03-30 | ||||
| 2010-09-30 | $3.92M 10-Q · filed 2011-11-09 | $8.12M derived: sum of 2 quarters · filed 2011-11-09 | $11.74M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $4.20M 10-Q/A · filed 2011-09-23 | $7.81M 10-Q/A · filed 2011-09-23 | ||||||
| 2009-12-31 | $10.47M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |